Aeroquin: Phase III data

The open-label, international Phase III 209 trial in 282 CF patients with P. aeruginosa infection showed that twice-daily 240 mg Aeroquin for the first 28

Read the full 253 word article

How to gain access

Continue reading with a
two-week free trial.